undamentalytics Newsletter
Sign in

60 Degrees Pharmaceuticals, Inc. balance sheet

At the end of fiscal 2025, 60 Degrees Pharmaceuticals, Inc. had total assets of $5.4m, total liabilities of $2.0m and shareholders' equity of $3.5m. It held $1.5m in cash against $152,775 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents02221
Receivables00011
Inventory10011
Total current assets17554
Total assets18654
Total current liabilities243222
Short-term debt—0000
Long-term debt170000
Total debt171000
Total liabilities253222
Shareholders' equity−245433
Non-controlling interests and other (assets − liabilities − equity)−1———−0
Shares outstanding————3m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SXTC vs SXTPSCNX vs SXTPLPCN vs SXTPNTRB vs SXTP

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from 60 Degrees Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to 60 Degrees Pharmaceuticals, Inc.